DexCom Analyst Price Targets - Benzinga

DexCom Inc

DXCMNASDAQ

Trade with Public

Trade with Public

$90.38

1.091.22%

Dern. MÀJ: Aug 28, 2:45 PM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

DexCom Analyst Price Targets

Wall Street analyst price targets and consensus rating for DexCom (DXCM).

Price Target Range — 9 Quarters

Analyst Consensus — 26 Analysts

1S.Buy

22Buy

2Hold

1Sell

Consensus RatingBuy# Analysts26Avg. Consensus PT$90Upside to Avg. PT-0.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 4, 2026	Argus Research	Steve Silver	PT Raise	Buy	$86→$96
Aug 3, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$82→$90
Jul 31, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$84→$88
Jul 31, 2026	RBC Capital	Kendall Au	PT Raise	Outperform	$85→$90
Jul 31, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$90→$95
Jul 31, 2026	JP Morgan	Robbie Marcus	PT Raise	Neutral	$65→$82
Jul 31, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$88→$95
Jul 31, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$85→$90
Jul 31, 2026	Stifel	Jonathan Block	PT Raise	Buy	$90→$95
Jul 31, 2026	Benchmark	Bruce D. Jackson	PT Raise	Buy	$77→$82
Jul 31, 2026	Truist Securities	Richard Newitter	PT Raise	Buy	$87→$93
Jul 31, 2026	BTIG	Marie Thibault	PT Raise	Buy	$80→$90
Jul 28, 2026	UBS	Patrick Wood	Reinstates	Buy	$96
Jul 16, 2026	Truist Securities	Richard Newitter	PT Raise	Buy	$80→$87
Jul 15, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$85→$90
Jun 23, 2026	Deutsche Bank	Kieran Ryan	Initiate	Buy	$86
Jun 15, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$75→$88
Jun 10, 2026	TD Cowen	Joshua Jennings	PT Raise	Buy	$75→$95
Jun 9, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$75→$85
Jun 5, 2026	Stifel	Jonathan Block	PT Raise	Buy	$85→$90

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Argus Research Maintains Buy on DexCom, Raises Price Target to $96

Argus Research analyst Steve Silver maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $86 to $96.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $90

Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $82 to $90.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on DexCom, Raises Price Target to $88

Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $84 to $88.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on DexCom, Raises Price Target to $90

RBC Capital analyst Kendall Au maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $85 to $90.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on DexCom, Raises Price Target to $95

Mizuho analyst Anthony Petrone maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $90 to $95.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on DexCom, Raises Price Target to $82

JP Morgan analyst Robbie Marcus maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $65 to $82.

Benzinga Newsdesk